Australia - angielski - Department of Health (Therapeutic Goods Administration)

ksj pharmatech - 62641 - multichannel electrocardiograph, interpretive, home-use - this device is intended to be used by licensed medical professionals or patients or anyone to obtain electrocardiogram (ecg) rhythms.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

ksj pharmatech - ct772 - severe acute respiratory syndrome-associated coronavirus ivds - intended to detect the novel coronavirus sars-cov-2 that causes covid-19 from symptomatic individuals for self-testing by lay persons (nasal swab).

Australia - angielski - Department of Health (Therapeutic Goods Administration)

forest pharmatech pty limited - colecalciferol, quantity: 2.4 microgram; retinol palmitate, quantity: 5000 iu - capsule, soft - excipient ingredients: soya oil; gelatin; purified water; glycerol - to be decided by overseas department of health

Australia - angielski - Department of Health (Therapeutic Goods Administration)

forest pharmatech pty limited - colecalciferol, quantity: 0.0096 mg; retinol palmitate, quantity: 5000 iu - capsule, soft - excipient ingredients: soya oil; gelatin; glycerol; purified water

Australia - angielski - Department of Health (Therapeutic Goods Administration)

ksj pharmatech - lidocaine hydrochloride monohydrate, quantity: 21.33 mg/g (equivalent: lidocaine hydrochloride, qty 20 mg/g) - gel - excipient ingredients: hyetellose; glycerol; sodium hydroxide; hydrochloric acid; water for injections - surface anaesthesia and lubrication for:,? the male and female urethra during cystoscopy, catheterization, exploration by sound and other endourethral operations. ,? nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy. ,? proctoscopy and rectoscopy.,? tracheal intubation,? cytoscopy and symptomatic treatment of painful cystitis and urethritis

Australia - angielski - Department of Health (Therapeutic Goods Administration)

forest pharmatech pty limited - chromium amino acid chelate, quantity: 10 mg; zinc oxide, quantity: 12.4533 mg; ferrous fumarate, quantity: 31.5457 mg; riboflavine, quantity: 25.5 mg; nicotinamide, quantity: 25.5 mg; manganese amino acid chelate, quantity: 7 mg; eleutherococcus senticosus, quantity: 5 mg (equivalent: eleutherococcus senticosus, qty 25 mg); potassium amino acid chelate, quantity: 25 mg; d-alpha-tocopherol, quantity: 51.5464 mg; ascorbic acid, quantity: 55 mg; lysine hydrochloride, quantity: 15.625 mg; pyridoxine hydrochloride, quantity: 25.5 mg; biotin, quantity: 0.025 mg; folic acid, quantity: 0.2295 mg; rutoside, quantity: 10 mg; choline bitartrate, quantity: 20.8768 mg; inositol, quantity: 10 mg; retinol palmitate, quantity: 2.5 mg; calcium hydrogen phosphate, quantity: 454.5455 mg; ubidecarenone, quantity: 0.5 mg; oryzanol, quantity: 3 mg; threonine, quantity: 3.6 mg; alanine, quantity: 6 mg; methionine, quantity: 2.7 mg; leucine, quantity: 4.69 mg; dl-phenylalanine, quantity: 4.17 mg; calcium caseinate, quantity: 9.9998 mg; ergocalciferol, quantity: 0.22 mg; heavy magnesium oxide, quantity: 45.4545 mg; hydroxocobalamin, quantity: 25 microgram; aminobenzoic acid, quantity: 10 mg - capsule, soft - excipient ingredients: vegetable oil; yellow beeswax; lecithin; gelatin; glycerol; hydrogenated vegetable oil; purified water; hydrogenated soya oil; pollen

Australia - angielski - Department of Health (Therapeutic Goods Administration)

forest pharmatech pty limited - squalene, quantity: 1 g - capsule, soft - excipient ingredients: gelatin; glycerol; purified water - squalene is extracted from selected shark liver oil.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

ksj pharmatech - curcuma longa, quantity: 145 mg (equivalent: curcuma longa, qty 3.625 g; equivalent: curcumin, qty 100 mg) - pastille - excipient ingredients: gelatin; sodium benzoate; sucralose; purified water; glycerol; orange oil; polysorbate 80; lecithin; spearmint oil - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; decrease/reduce/relieve mild joint inflammation/swelling ; decrease/reduce/relieve mild joint pain/soreness

Australia - angielski - Department of Health (Therapeutic Goods Administration)

ksj pharmatech - neostigmine methylsulfate, quantity: 2.5 mg; glycopyrronium bromide, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid; dibasic sodium phosphate dodecahydrate - reversal of residual non-depolarising (competitive) neuromuscular block.

Izrael - angielski - Ministry of Health

lapidot medical import and marketing ltd - lidocaine hydrochloride monohydrate - solution for injection - lidocaine hydrochloride monohydrate 20 mg/ml - lidocaine - local and regional anaesthesia.severe symptomatic ventricular tachycardia or tachy-arrhythmia, if assessed to be life-threatening.